Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
Kaklamani VG, Baddi L, Liu J, Rosman D, Phukan S, Bradley C, Hegarty C, McDaniel B, Rademaker A, Oddoux C, Ostrer H, Michel LS, Huang H, Chen Y, Ahsan H, Offit K, Pasche B.
Kaklamani VG, et al.
Cancer Res. 2005 Apr 15;65(8):3454-61. doi: 10.1158/0008-5472.CAN-04-2961.
Cancer Res. 2005.
PMID: 15833881